Mereo BioPharma Group plc - Ordinary Shares, nominal value EURO0.003 per share, represented by American Depository Shares (MREO)

Historical Holders from Q2 2019 to Q1 2025

Symbol
MREO on Nasdaq
CUSIP
589492107
Type / Class
Equity / Ordinary Shares, nominal value EURO0.003 per share, represented by American Depository Shares
Shares outstanding
791M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
115M
Holdings value
$403M
% of all portfolios
0.003%
Grand Portfolio weight change
+0%
Number of holders
90
Number of buys
35
Number of sells
-30
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Mereo BioPharma Group plc - Ordinary Shares, nominal value EURO0.003 per share, represented by American Depository Shares (MREO)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ADAGE CAPITAL PARTNERS GP, L.L.C. 5.62% $98M 43.6M Adage Capital Management, L.P. Dec 31, 2024
Frazier Life Sciences Public Fund, L.P. 5.1% $90.8M 40.3M James N. Topper Apr 1, 2025
JANUS HENDERSON GROUP PLC 11% $38.5M 17.1M JANUS HENDERSON GROUP PLC Dec 31, 2024

Institutional Holders of Mereo BioPharma Group plc - Ordinary Shares, nominal value EURO0.003 per share, represented by American Depository Shares (MREO)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 82K $188K +$9.16K $2.25 6
2024 Q4 115M $403M +$29.7M $3.50 90
2024 Q3 106M $435M +$21.8M $4.11 76
2024 Q2 101M $362M +$59.9M $3.60 76
2024 Q1 84M $277M +$15.2M $3.30 77
2023 Q4 78.5M $181M +$12.8M $2.31 59
2023 Q3 69.9M $90.2M +$9.9M $1.29 52
2023 Q2 63.6M $84M +$2.51M $1.32 48
2023 Q1 60.8M $43M -$705K $0.71 56
2022 Q4 61.4M $46.1M -$7.73M $0.75 56
2022 Q3 68M $58.5M -$7.13M $0.86 56
2022 Q2 73.6M $82.5M -$16.9M $1.12 58
2022 Q1 88.9M $99.6M -$3.07M $1.12 55
2021 Q4 90.9M $145M -$12.2M $1.60 67
2021 Q3 87.5M $212M -$26.6M $2.42 57
2021 Q2 89.6M $284M -$2.19M $3.17 68
2021 Q1 90.2M $304M +$111M $3.37 65
2020 Q4 57.1M $205M +$140M $3.58 42
2020 Q3 14.3M $37.4M +$18M $2.62 20
2020 Q2 7.27M $22.3M +$12.8M $3.06 18
2020 Q1 1.4K $1K -$469K $0.71 1
2019 Q4 1.23M $4.05M -$2.32M $3.28 8
2019 Q3 1.76M $5.13M -$79.4K $2.94 12
2019 Q2 1.72M $4.19M +$4.19M $2.44 13